Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01137890 · ClinicalTrials.gov registry record · Phase 1
Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT01137890: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT01137890 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01137890, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
This is a residential pilot trial to evaluate the pharmacodynamic interaction between zonisamide and cocaine, with the goal of evaluating zonisamide's potential for the treatment of cocaine dependence.
Interventions
- DRUG Placebo
- DRUG Zonisamide
- DRUG Cocaine Hydrochloride
- BEHAVIORAL Neurocognitive and Performance Battery
- BEHAVIORAL Smoking Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01137890
The ClinicalTrials.gov registry entry for NCT01137890 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT01137890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01137890 about?
NCT01137890 is a clinical study titled "Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse". This is a residential pilot trial to evaluate the pharmacodynamic interaction between zonisamide and cocaine, with the goal of evaluating zonisamide's potential for the treatment of cocaine dependence.
What is the current status of trial NCT01137890?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2010-06. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01137890?
The interventions under investigation include: Placebo (DRUG), Zonisamide (DRUG), Cocaine Hydrochloride (DRUG), Neurocognitive and Performance Battery (BEHAVIORAL), Smoking Assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT01137890?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.